Clinial research on efficacy of statins in preventing contrast-induced nephropathy

Pharmaceutical Care and Research

Volumn 11, Issue 2, 2011, Pages 111-114

  Lu, Yang ^a   Zhao, XianXian ^a   Qin, YongWen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Contrast induced nephropathy; Neutrophil gelatinase associated lipocalin; Percutaneous coronary intervention; Statins

Indexed keywords

ATORVASTATIN; CREATININE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SIMVASTATIN; UREA;

ANGIOCARDIOGRAPHY; ARTICLE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME; UREA BLOOD LEVEL;

EID: 79957461024     PISSN: 16712838     EISSN: None     Source Type: Journal    
DOI: 10.5428/pcar20110212     Document Type: Article

References (12)

1. Waybill M M, Waybill P N. Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention[J]. J Vasc Interv Radiol, 2001,12(1):3-9.
2. Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: clinical and evidence-based approach[J]. Circulation, 2006,113(14):1799-1806.
3. McCullough P. Outcomes of contrast-induced nephropathy, experience in patients undergoing cardiovascular intervention [J]. Catheter Cardiovasc Interv, 2006,67(3):335-343.
4. Kjeldsen L, Johnsen A H, Sengelφv H, et al. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase[J]. J Biol Chem, 1993,268(14):10425-10432.
5. Mishra J , Mori K, Ma Q, et al. Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin[J]. J Am Soc Nephrol, 2004,15(12):3073-3082.
6. Trof R J, Di Maggio F, Leemreis J, et al. Biomarkers of acute renal injury and renal failure[J]. Shock, 2006,26(3):245-253.
7. Ma Y C, Zuo L, Chen J H, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease[J]. J Am Soc Nephrol, 2006,17(10):2937-2944.
8. Khanal S, Attallah N, Smith D E, et al. Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions[J]. Am J Med, 2005,118(8):843-849.
9. Attallah N, Yassine L, Musial J, et al. The potential role of Statins in contrast nephropathy[J]. Clin Nephrol, 2004,62(4):273-278.
10. Zhao JingLin, Yang YueJin, Zhang YuanHui, et al. Effect of statins on contrast-induced nephropathy in patients with acute myocardial infarction treated with primary angioplasty[J]. Int J Cardiol, 2008,126(3):435-436.
11. Park J K, Müller D N, Mervaala E M, et al. Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure and cholesterol-lowering effects [J]. Kidney Int, 2000,58(4):1420-1430.
12. Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery [J]. Lancet, 2005,365(9466):1231-1238.